Related references
Note: Only part of the references are listed.Perspective: The future of liquid biopsy
Catherine Alix-Panabieres
NATURE (2020)
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Ryan Woodhouse et al.
PLOS ONE (2020)
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Klaus Pantel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Circulating Tumor Cell Detection in Lung Cancer: But to What End?
Veronique Hofman et al.
CANCERS (2019)
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer
Natasha B. Leighl et al.
CLINICAL CANCER RESEARCH (2019)
Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer
Cheol-Kyu Park et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Accuracy and complications of CT-guided pulmonary core biopsy in small nodules: a single-center experience
Ming-De Huang et al.
CANCER IMAGING (2019)
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK plus Lung Cancer
Leora Horn et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA
Julianna G. Supplee et al.
LUNG CANCER (2019)
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
Francesca Chemi et al.
NATURE MEDICINE (2019)
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
J. Zugazagoitia et al.
ANNALS OF ONCOLOGY (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer
Charu Aggarwal et al.
JAMA ONCOLOGY (2019)
Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non-Small Cell Lung Cancer
Caroline E. McCoach et al.
CLINICAL CANCER RESEARCH (2018)
Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions
Marius Ilie et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer
Benjamin J. Solomon et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Christian Rolfo et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D. Planchard et al.
ANNALS OF ONCOLOGY (2018)
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer
Solange Peters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients
Paul Hofman
CANCERS (2017)
Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer
Chye Ling Tan et al.
ONCOTARGET (2016)
Noninvasive genotyping and monitoring of anaplastic lymphoma kinase (ALK) rearranged non-small cell lung cancer by capture-based next-generation sequencing
Ye Wang et al.
ONCOTARGET (2016)
Molecular analysis of circulating tumour cells-biology and biomarkers
Matthew G. Krebs et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non-Small-Cell Lung Cancer
Emma Pailler et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
ALK in Lung Cancer: Past, Present, and Future
Alice T. Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma
M. Ilie et al.
ANNALS OF ONCOLOGY (2012)
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
Matthew G. Krebs et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
F. Farace et al.
BRITISH JOURNAL OF CANCER (2011)
Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
Veronique Hofman et al.
CLINICAL CANCER RESEARCH (2011)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK
Alice T. Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Share Paper
